Effects of glucagon-like peptide-1 receptor agonists on kidney function and safety in type 2 diabetes patients

被引：4
|
作者：
Kim, Min Kyung [1 ]
Kim, Doo-Man [1 ]
机构：
[1] Hallym Univ, Coll Med, Dept Internal Med, Div Endocrinol,Kangdong Sacred Heart Hosp, Seoul, South Korea
来源：
JOURNAL OF DIABETES INVESTIGATION | 2021年 / 12卷 / 06期
关键词：
D O I：
10.1111/jdi.13552
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Glucagon-like peptide-1 receptor agonists have been recommended in diabetic kidney disease patients.
引用
收藏
页码：914 / 916
页数：3
相关论文
共 50 条
  • [41] Glucagon-like peptide-1 receptor agonists and safety in the preconception period
    Minis, Evelyn
    Stanford, Fatima Cody
    Mahalingaiah, Shruthi
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2023, 30 (06) : 273 - 279
  • [42] Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
    Fu-Shun Yen
    Ming-Chih Hou
    James Cheng-Chung Wei
    Ying-Hsiu Shih
    Chii-Min Hwu
    Chih-Cheng Hsu
    BMC Medicine, 22
  • [43] Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
    Yen, Fu-Shun
    Hou, Ming-Chih
    Wei, James Cheng-Chung
    Shih, Ying-Hsiu
    Hwu, Chii-Min
    Hsu, Chih-Cheng
    BMC MEDICINE, 2024, 22 (01)
  • [44] Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?
    Li, Yuanyuan
    Wang, Xiaoze
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (05) : 1142 - 1143
  • [45] Glucagon-Like Peptide-1 Receptor Agonists and Brain Vascular Function
    Begic, Edin
    Causevic, Mirsada
    HEART LUNG AND CIRCULATION, 2021, 30 (11): : 1675 - 1680
  • [46] Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?
    Resnick, Ortal
    Bril, Fernando
    Beauchamp, Giovanna
    FRONTIERS IN ENDOCRINOLOGY, 2025, 15
  • [47] Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?
    Li, Yuanyuan
    Wang, Xiaoze
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (04) : 1142 - 1143
  • [48] Glucagon-Like Peptide-1 Receptor Agonists Reduction in Stroke Type 2 DM Patients
    Alhawyan, Fatmah Salem
    Althobaiti, Mohammed Adel
    Alnami, Hashim Yahya
    Allahafi, Hadeel Ibrahim
    Almalky, Ayman Jamaan
    Al Johani, Sultan Ahmed
    Shiban, Rokayah Hussain
    Saddah, Mohammed Ahmed
    Alamrah, Hussam Mohammed
    Aljuhani, Moayad Zeyad
    Alfallaj, Ebtehal Hamid
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2020, 10 (05): : 122 - 128
  • [49] Safety and Efficacy of Switching Patients With Type 2 Diabetes From Glucagon-Like Peptide-1 Receptor Agonists to Tirzepatide: A Case Series
    Barakat, Sami
    Ramdeen, Shannon
    Khaimova, Rebecca
    HOSPITAL PHARMACY, 2024, 59 (06) : 614 - 619
  • [50] EFFICACY AND SAFETY OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS THERAPY INITIATION IN PATIENTS WITH TYPE 2 DIABETES HOSPITALIZED WITH CORONAVIRUS INFECTION
    Markova, Tatiana N.
    Lysenko, Mariana A.
    Stas, Mukhamed S.
    Anchutina, Anastasia A.
    DIABETES MELLITUS, 2023, 26 (06): : 537 - 548
12345